Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase

[1]  K. Chou Structural bioinformatics and its impact to biomedical science. , 2004, Current medicinal chemistry.

[2]  K. Chou,et al.  Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide , 2004, Peptides.

[3]  Kuo-Chen Chou,et al.  Virtual Screening for SARS-CoV Protease Based on KZ7088 Pharmacophore Points , 2004, J. Chem. Inf. Model..

[4]  K. Nakagaki,et al.  N-Terminal Domain of the Murine Coronavirus Receptor CEACAM1 Is Responsible for Fusogenic Activation and Conformational Changes of the Spike Protein , 2004, Journal of Virology.

[5]  K. Shortridge Severe acute respiratory syndrome and influenza: virus incursions from southern China. , 2003, American journal of respiratory and critical care medicine.

[6]  G. Gao,et al.  The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Feng Gao,et al.  Prediction of proteinase cleavage sites in polyproteins of coronaviruses and its applications in analyzing SARS-CoV genomes , 2003, FEBS Letters.

[8]  Kuo-Chen Chou,et al.  Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS , 2003, Biochemical and Biophysical Research Communications.

[9]  Ren Zhang,et al.  ZCURVE_CoV: a new system to recognize protein coding genes in coronavirus genomes, and its applications in analyzing SARS-CoV genomes , 2003, Biochemical and Biophysical Research Communications.

[10]  Rolf Hilgenfeld,et al.  Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs , 2003, Science.

[11]  Christian Drosten,et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[12]  J. A. Comer,et al.  A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[13]  Kuo-Chen Chou,et al.  Identification of the N‐terminal functional domains of Cdk5 by molecular truncation and computer modeling , 2002, Proteins.

[14]  C. Soto,et al.  Converting a peptide into a drug: strategies to improve stability and bioavailability. , 2002, Current medicinal chemistry.

[15]  Kuo-Chen Chou,et al.  Prediction of the Tertiary Structure of the β-Secretase Zymogen☆ , 2002 .

[16]  Kuo-Chen Chou,et al.  Prediction of the tertiary structure of the beta-secretase zymogen. , 2002, Biochemical and biophysical research communications.

[17]  K. Chou,et al.  Prediction of the tertiary structure of a caspase‐9/inhibitor complex , 2000, FEBS letters.

[18]  K D Watenpaugh,et al.  A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator. , 1999, Biochemical and biophysical research communications.

[19]  Junying Yuan,et al.  Solution Structure of BID, an Intracellular Amplifier of Apoptotic Signaling , 1999, Cell.

[20]  Gerhard Wagner,et al.  Solution Structure of the RAIDD CARD and Model for CARD/CARD Interaction in Caspase-2 and Caspase-9 Recruitment , 1998, Cell.

[21]  K. Chou,et al.  Prediction of the tertiary structure and substrate binding site of caspase‐8 , 1997, FEBS letters.

[22]  Æleen Frisch,et al.  Exploring chemistry with electronic structure methods , 1996 .

[23]  K. Chou Prediction of human immunodeficiency virus protease cleavage sites in proteins. , 1996, Analytical biochemistry.

[24]  K. Chou,et al.  A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins. , 1993, The Journal of biological chemistry.

[25]  M. Karplus,et al.  Functionality maps of binding sites: A multiple copy simultaneous search method , 1991, Proteins.

[26]  P. Goodford A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[27]  Dm Jones,et al.  H-77: a potent new renin inhibitor. In vitro and in vivo studies , 1982 .